Do glucocorticoids increase SHBG production in human liver cells?

The interaction between glucocorticoids and hepatic function is a critical area of endocrinology, particularly regarding the regulation of sex hormone-binding globulin (SHBG). In human liver cells, this relationship is complex and mediated by a network of nuclear receptors.

Mechanistic explanations

The regulation of SHBG production in human hepatocytes centers on the activity of Hepatocyte Nuclear Factor-4α (HNF-4α). This factor is the primary driver of the SHBG promoter; without its binding, SHBG transcription is minimal. Glucocorticoids, acting through the Glucocorticoid Receptor (GR), are known to influence HNF-4α activity in several ways:

• Transcriptional Interaction: GR and HNF-4α exhibit significant cross-talk on liver chromatin. Evidence indicates that HNF-4α can modulate GR binding sites, and glucocorticoids can influence pathways regulated by HNF-4α.
• Metabolic Reprogramming: Glucocorticoids are potent regulators of hepatic metabolism. They can induce hepatic lipogenesis and alter insulin signaling, both of which are metabolic states known to suppress HNF-4α.
• Competing Repressors: Metabolic stressors can lead to the recruitment of COUP-TF1, which competes for the same binding sites as HNF-4α on the SHBG promoter, effectively repressing transcription.

Clinical and experimental evidence

While the mechanism for interaction exists, the specific claim that glucocorticoids increase SHBG production lacks strong direct experimental support in isolated human liver models:

• Cell Models: Studies using HepG2 cells and primary human hepatocytes—the gold standards for SHBG research—confirm that these cells produce SHBG and respond to glucocorticoids via GR. However, these models often show that metabolic changes induced by glucocorticoids (like increased fat accumulation) tend to decrease rather than increase SHBG.
• Indirect Effects: In clinical settings, the effects of glucocorticoids on SHBG are often confounded by changes in insulin levels or thyroid status, both of which are powerful regulators of SHBG production.

Bottom line

While it is established that glucocorticoids act on human liver cells and that these cells produce SHBG, the claim that glucocorticoids directly increase SHBG production is only plausible and lacks definitive experimental confirmation. Current evidence suggests that the relationship is highly context-dependent, with glucocorticoids often indirectly suppressing SHBG by modulating metabolic pathways and HNF-4α activity.